CHINWE OBINWA: Open Payments
NPI 1053701102 · BETHESDA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$917 in 35 payments from 12 companies in 2025. Trend: 2023 $53 · 2024 $152 · 2025 $917
Food & beverage: $917
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $207 |
| Sumitomo Pharma America, Inc. | 10 | $167 |
| Endo USA, Inc. | 7 | $154 |
| TOLMAR, INC. | 3 | $87 |
| ABC Home Medical Supply, Inc. | 2 | $70 |
| Ferring Pharmaceuticals Inc. | 3 | $63 |
| 180 Medical, Inc. | 2 | $46 |
| Janssen Biotech, Inc. | 1 | $34 |
| Valencia Technologies Corporation | 1 | $26 |
| UROGEN PHARMA, INC. | 1 | $25 |
Products named: AVEED, AMS 700, ORGOVYX, GEMTESA, ADSTILADRIN, ELIGARD, Rezum Generator, ERLEADA.
Industry payments across MD — which companies pay providers there.
